Effect of Calcitriol and Pamidronate in Multiple Myeloma
- 1 July 1999
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 318 (1) , 61-6
- https://doi.org/10.1097/00000441-199907000-00010
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Reduced Tyk2/SHP-1 interaction and lack of SHP-1 mutation in a kindred of familial hemophagocytic lymphohistiocytosisLeukemia, 1998
- Multiple MyelomaNew England Journal of Medicine, 1997
- Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple MyelomaNew England Journal of Medicine, 1996
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- The Treatment of Multiple MyelomaNew England Journal of Medicine, 1994
- 1,25-Dihydroxyvitamin D 3 : a Novel Immunoregulatory HormoneScience, 1984
- 1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor.Journal of Clinical Investigation, 1984
- 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.The Journal of cell biology, 1984
- Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implicationsBlood, 1983
- 1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cellsBiochemical and Biophysical Research Communications, 1981